HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53

Cell Cycle

Volumn 11, Issue 22, 2012, Pages 4181-4190

  Xue, Yuwen ^a,b   Chen, Jian ^b   Choi, Hyun Ho ^b   Phan, Liem ^b   Chou, Ping Chieh ^b   Zhao, Ruiying ^b   Yang, Huiling ^b   Santiago, Janice ^b   Liu, Mo ^b   Yeung, Giselle E ^b   Yeung, Sai Ching J ^b   Lee, Mong Hong ^b,c  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Akt; Cell cycle; CSN6; HER2; p53

Indexed keywords

COP9 SIGNALOSOME; CSN6 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN KINASE B; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; HUMAN; HUMAN CELL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 84869443068     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.22413     Document Type: Article

References (36)

1. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235:177-82; PMID:3798106; http://dx.doi.org/ 10.1126/science.3798106.
2. Lee MH, Yang HY. Negative regulators of cyclin-dependent kinases and their roles in cancers. Cell Mol Life Sci 2001; 58:1907-22; PMID:11766887; http://dx.doi.org/10.1007/PL00000826.
3. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC. Cytoplasmic localization of p21Cip1/WAF1 by Aktinduced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 2001; 3:245-52; PMID:11231573; http://dx.doi.org/10.1038/35060032.
4. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002; 2:489-501; PMID:12094235.
5. Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci USA 1998; 95:15587-91; PMID:9861013; http://dx.doi.org/10.1073/pnas.95.26.15587.
6. Scheid MP, Woodgett JR. PKB/AKT: functional insights from genetic models. Nat Rev Mol Cell Biol 2001; 2:760-8; PMID:11584303; http://dx.doi.org/10.1038/ 35096067.
7. Tomoda K, Kubota Y, Kato J. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 1999; 398:160-5; PMID:10086358; http://dx.doi.org/10.1038/18230.
8. Naumann M, Bech-Otschir D, Huang X, Ferrell K, Dubiel W. COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK. J Biol Chem 1999; 274:35297-300; PMID:10585392; http://dx.doi.org/10.1074/jbc.274. 50.35297.
9. Bech-Otschir D, Kraft R, Huang X, Henklein P, Kapelari B, Pollmann C, et al. COP9 signalosomespecific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J 2001; 20:1630-9; PMID:11285227; http://dx.doi.org/10. 1093/emboj/20.7.1630.
10. Zhao R, Yeung SC, Chen J, Iwakuma T, Su CH, Chen B, et al. Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. J Clin Invest 2011; 121:851-65; PMID:21317535; http://dx.doi.org/10.1172/JCI44111.
11. Choi HH, Gully C, Su CH, Velazquez-Torres G, Chou PC, Tseng C, et al. COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σ. Oncogene 2011; 30:4791-801; PMID:21625211; http://dx.doi.org/10.1038/onc.2011.192.
12. Wei N, Deng XW. The COP9 signalosome. Annu Rev Cell Dev Biol 2003; 19:261-86; PMID:14570571; http://dx.doi.org/10.1146/annurev.cell-bio.19.111301. 112449.
13. Lee MH, Zhao R, Phan L, Yeung SJ. Roles of COP9 signalosome in cancers. Cell Cycle 2011;10: 3057-66; http://dx.doi.org/10.4161/cc.10.18.17320.
14. Karniol B, Chamovitz DA. The COP9 signalosome: from light signaling to general developmental regulation and back. Curr Opin Plant Biol 2000; 3:387-93; PMID:11019806; http://dx.doi.org/10.1016/S1369-5266(00)00101-1.
15. Li L, Deng XW. The COP9 signalosome: an alternative lid for the 26S proteasome? Trends Cell Biol 2003; 13:507-9; PMID:14507477; http://dx.doi.org/ 10.1016/j.tcb.2003.08.002.
16. Zhou BP, Liao Y, Xia W, Zou Y, Spohn B, Hung MC. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 2001; 3:973-82; PMID:11715018; http://dx.doi.org/10.1038/ncb1101-973.
17. Lee MH, Lozano G. Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins. Semin Cancer Biol 2006; 16:225-34; PMID:16697215; http://dx.doi.org/10.1016/j.semcancer.2006.03.009.
18. Yang H, Wen YY, Zhao R, Lin YL, Fournier K, Yang HY, et al. DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer. Cancer Res 2006; 66:3096-105; PMID:16540659; http://dx.doi.org/10.1158/0008-5472.CAN-05-3620.
19. Rinaldi T, Bolotin-Fukuhara M, Frontali L. A Saccharomyces cerevisiae gene essential for viability has been conserved in evolution. Gene 1995; 160:135-6; PMID:7628709; http://dx.doi.org/10.1016/0378-1119(95)00212-O.
20. Penney M, Wilkinson C, Wallace M, Javerzat JP, Ferrell K, Seeger M, et al. The Pad1+ gene encodes a subunit of the 26 S proteasome in fission yeast. J Biol Chem 1998; 273:23938-45; PMID:9727008; http://dx.doi.org/10.1074/jbc.273. 37.23938.
21. Wei N, Deng XW. Making sense of the COP9 signalosome. A regulatory protein complex conserved from Arabidopsis to human. Trends Genet 1999; 15:98-103; PMID:10203806; http://dx.doi.org/10.1016/S0168-9525(98)01670-9.
22. Maytal-Kivity V, Reis N, Hofmann K, Glickman MH. MPN+, a putative catalytic motif found in a subset of MPN domain proteins from eukaryotes and prokaryotes, is critical for Rpn11 function. BMC Biochem 2002; 3:28; PMID:12370088; http://dx.doi.org/10.1186/1471-2091-3-28.
23. Lyapina S, Cope G, Shevchenko A, Serino G, Tsuge T, Zhou C, et al. Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science 2001; 292:1382-5; PMID:11337588; http://dx.doi.org/10.1126/science.1059780.
24. Mahalingam S, Ayyavoo V, Patel M, Kieber-Emmons T, Kao GD, Muschel RJ, et al. HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycle. Proc Natl Acad Sci USA 1998; 95:3419-24; PMID:9520381; http://dx.doi.org/10.1073/pnas.95.7. 3419.
25. Amini S, Saunders M, Kelley K, Khalili K, Sawaya BE. Interplay between HIV-1 Vpr and Sp1 modulates p21(WAF1) gene expression in human astrocytes. J Biol Chem 2004; 279:46046-56; PMID:15302882; http://dx.doi.org/10.1074/jbc. M403792200.
26. Yang H, Zhang Y, Zhao R, Wen YY, Fournier K, Wu HB, et al. Negative cell cycle regulator 14-3-3sigma stabilizes p27 Kip1 by inhibiting the activity of PKB/Akt. Oncogene 2006; 25:4585-94; PMID:16532026; http://dx.doi.org/10.1038/sj. onc.1209481.
27. Jin J, Ang XL, Shirogane T, Wade Harper J. Identification of substrates for F-box proteins. Methods Enzymol 2005; 399:287-309; PMID:16338364; http://dx.doi.org/10.1016/S0076-6879(05)99020-4.
28. Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 2008; 8:83-93; PMID:18094723.
29. Onoyama I, Nakayama KI. Fbxw7 in cell cycle exit and stem cell maintenance: insight from gene-targeted mice. Cell Cycle 2008; 7:3307-13; PMID:18948752; http://dx.doi.org/10.4161/cc.7.21.6931.
30. Minella AC, Clurman BE. Mechanisms of tumor suppression by the SCF(Fbw7). Cell Cycle 2005; 4:1356-9; PMID:16131838; http://dx.doi.org/10.4161/cc.4.10. 2058.
31. Wang Z, Inuzuka H, Fukushima H, Wan L, Gao D, Shaik S, et al. Emerging roles of the FBW7 tumour suppressor in stem cell differentiation. EMBO Rep 2012; 13:36-43; PMID:22157894; http://dx.doi.org/10.1038/embor.2011.231.
32. Wu CC, Yang TY, Yu CT, Phan L, Ivan C, Sood AK, et al. p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation. Cell Cycle 2012; 11:3433-42; PMID:22894933; http://dx.doi.org/10.4161/cc.21732.
33. Su CH, Zhao R, Zhang F, Qu C, Chen B, Feng YH, et al. 14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability. Cancer Res 2011; 71:884-94; PMID:21135113; http://dx.doi.org/10.1158/0008-5472.CAN-10-2518.
34. Su CH, Zhao R, Velazquez-Torres G, Chen J, Gully C, Yeung SC, et al. Nuclear export regulation of COP1 by 14-3-3σ in response to DNA damage. Mol Cancer 2010; 9:243; PMID:20843328; http://dx.doi.org/10.1186/1476-4598-9- 243.
35. Yang HY, Wen YY, Chen CH, Lozano G, Lee MH. 14-3-3 sigma positively regulates p53 and suppresses tumor growth. Mol Cell Biol 2003; 23:7096-107; PMID:14517281; http://dx.doi.org/10.1128/MCB.23.20.7096-7107.2003.
36. Laronga C, Yang HY, Neal C, Lee MH. Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem 2000; 275:23106-12; PMID:10767298; http://dx.doi.org/10.1074/jbc. M905616199.